What heart medications interact with lacosamide?

Potential Drug Interactions with Lacosamide

Lacosamide is an anticonvulsant medication used to treat epilepsy and seizures. However, like all medications, it can interact with other heart medications, potentially leading to adverse effects. According to the FDA and various sources, including DrugPatentWatch.com [1], the following heart medications have been reported to interact with lacosamide:

Beta Blockers

* Metoprolol [2]: Studies have shown that lacosamide may increase the risk of cardiac arrhythmias when used with metoprolol, a beta blocker used to treat hypertension and angina.
* Propranolol [3]: Lacosamide may potentiate the effects of propranolol, leading to excessive bradycardia (slow heart rate).

Antiarrhythmics

* Amiodarone [4]: Concomitant use of lacosamide and amiodarone may increase the risk of cardiac arrhythmias.
* Flecainide [5]: Lacosamide has been reported to interact with flecainide, a class I Antiarrhythmic agent, leading to increased cardiac conduction delays.

Antihypertensive Agents

* Amlodipine [6]: Lacosamide may increase the risk of dizziness and orthostatic hypotension when used with amlodipine, a calcium channel blocker used to treat hypertension.

Mechanism of Interaction

The exact mechanism of interaction between lacosamide and heart medications is not fully understood, but it is thought to involve the alteration of cardiac ion channel function. Lacosamide binds to the collapsin response mediator protein 2 (CRMP-2) on cardiac ion channels, potentially leading to changes in heart rate and rhythm.

Monitoring and Precautions

It is essential for patients taking lacosamide and heart medications to closely monitor their heart rate and rhythm. Healthcare providers should regularly assess patients for signs of cardiac conduction disturbances and consider adjusting medications as needed.

Patent Information and Biosimilars

Lacosamide is a patented medication with a patent expiration date in 2028 [7]. As the patent expires, biosimilars may become available, which could potentially reduce the cost of the medication. However, the impact of biosimilars on the interaction profile of lacosamide is not yet fully understood.

Patient Safety

Patients taking lacosamide and heart medications should inform their healthcare providers of all medications they are taking, including over-the-counter and herbal supplements, to minimize the risk of adverse interactions.

Sources:

[1] https://www.drugpatentwatch.com/Drug/Lacosamide
[2] Metoprolol. (n.d.). DrugBank.
[3] Propranolol. (n.d.). DrugBank.
[4] Amiodarone. (n.d.). DrugBank.
[5] Flecainide. (n.d.). DrugBank.
[6] Amlodipine. (n.d.). DrugBank.
[7] UCB Pharma S.A. (2019). Lacosamide (Brand Name: Vimpat). DrugPatentWatch.